Human Anti-SLAMF7 Recombinant Antibody; Fab Fragment (HPAB-AP800-YC-F(E)) (CAT#: HPAB-AP800-YC-F(E))
This product is a recombinant Human antibody Fab fragment that recognizes SLAMF7. The antibody was purified by affinity chromatography.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

(Immunofluorescent staining of human cell line SK-MEL-30 shows localization to vesicles.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/61654/1269_D5_1_selected.jpg

(Spermatogonia cells Staining: Medium Intensity: Moderate)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/55945/134333_A_6_6.jpg

(Enterocytes - Mucosal lymphoid cells Staining: High Intensity: Strong)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/55945/134333_A_9_3.jpg

(Hepatocytes Staining: Low Intensity: Moderate Quantity: <25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/55945/134333_A_7_4.jpg

(Cells in tubules Staining: Medium Intensity: Moderate Quantity: 75%-25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/55945/134333_A_8_5.jpg

(Cell lines ordered by descending RNA expression order)
* Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000026751-SLAMF7
Specifications
- Immunogen
- The purified recombinant human CS1 ECD-γ3 fusion protein
- Host Species
- Human
- Derivation
- Chimeric (Mouse/Human)
- Type
- Chimeric (Mouse/Human) Fab
- Specificity
- Human SLAMF7
- Species Reactivity
- Human
- Applications
- ELISA, FC, IHC, Inhib, ADCC, FuncS
- Related Disease
- Autoimmune disorders and Cancer
Product Property
- Purity
- >95% as determined by SDS-PAGE
- Concentration
- Please refer to the vial label for the specific concentration.
- Buffer
- PBS
- Preservative
- No preservatives
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- 19A; CS1; CD319; CRACC; SLAM family member 7; 19A24 protein; CD2 subset 1; CD2-like receptor activating cytotoxic cells; membrane protein FOAP-12; novel LY9 (lymphocyte antigen 9) like protein; protein 19A
- Gene ID
- 59272
- UniProt ID
- Q9NQ25
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "SLAMF7"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-743 | Anti-SLAMF7 Recombinant Antibody (Elotuzumab) | FuncS, IF, Neut, ELISA, FC, IP, IHC | IgG1 - kappa |
TAB-570CL | Human Anti-SLAMF7 Recombinant Antibody (TAB-570CL) | IF, IHC, Inhib | Human IgG |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for HPAB-AP800-YC-F(E). Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: Neut, ELISA, IF, IP, FuncS, FC, IHC
Application: Inhib, Cyt
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: WB, IHC, ELISA, FC
Application: WB, ELISA, IF, FuncS, Apop, BA
Application: FC, FuncS, IA, IF, IP, IHC
Application: Neut, IHC, Activ, FuncS, IF, ELISA
For Research Use Only. Not For Clinical Use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.